• PIN22 LOS COSTOS DE LA NEUMONIA ADQUIRIDA EN LA COMUNIDAD Y LA LACTANCIA MATERNA COMO FACTOR DE PROTECCION EN MENORES DE 5 ANHOS EN HOSPITAL PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PSY3 SECUKINUMAB VS ADALIMUMAB E INFLIXIMAB PARA EL TRATAMIENTO DE ESPONDILITIS ANQUILOSANTE: UN ANÁLISIS DE COSTO POR RESPONDEDOR A LA SEMANA 24 DESDE UNA PERSPECTIVA COLOMBIANA

    Oct 1, 2019, 00:00

  • PIN9 PUBLIC HEALTH AND ECONOMIC IMPACT OF A GENDER-NEUTRAL QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN COLOMBIA

    Oct 1, 2019, 00:00

  • PBI3 ANÁLISIS DEL COSTO POR RESPONDEDOR DE SECUKINUMAB VS INFLIXIMAB Y ETANERCEPT PARA EL TRATAMIENTO DE LA ARTRITIS PSORIÁSICA DESDE UNA PERSPECTIVA ECUATORIANA

    Oct 1, 2019, 00:00

  • CM2 REMOTE MONITORING AFTER THE IMPLANTATION OF A CARDIOVERTER-DEFIBRILLATOR: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2019, 00:00

  • HT2 DISEÑO E IMPLEMENTACIÓN DE UN PROCESO DE INVOLUCRAMIENTO ACTIVO DE ACTORES RELEVANTES EN UNA AGENCIA DE EVALUACIÓN DE TECNOLOGÍAS SANITARIAS DE ARGENTINA

    Oct 1, 2019, 00:00

  • PMS5 USE OF AN ALGORITHM WITHIN A MULTIDISCIPLINARY CONSULTATION FOR THE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS CANDIDATES FOR BIOLOGICAL THERAPY - A STRATEGY FOR OPTIMIZING COSTS

    Oct 1, 2019, 00:00

  • PCV13 EFECTIVIDAD DEL CATETER VENOSO DE INSERCION CENTRAL VS EL CATETER VENOSO CENTRAL DE INSERCION PERIFERICA EN EL TRATAMIENTO DE PACIENTES EN LA UNIDAD DE CUIDADOS INTENSIVOS.

    Oct 1, 2019, 00:00

  • PNS49 EVOLUTION AND RESULTS OF HEALTHCARE PERFORMANCE INDICATORS IN BRAZILIAN SELF-FUNDED HEALTH PLANS

    Oct 1, 2019, 00:00

  • PRO6 BURDEN OF ILLNESS OF SPINAL MUSCULAR ATROPHY TYPE 1

    Oct 1, 2019, 00:00

  • PMS18 COST-ANALYSIS OF TREATMENT FOR MODERATE AND SEVERE RHEUMATOID ARTHRITIS IN A SPECIALIZED RHEUMATOLOGY CENTER

    Oct 1, 2019, 00:00

  • CE3 ECONOMIC EVALUATION OF THE USE OF PRE-FILLED SYRINGE VERSUS MANUALLY FILLED SYRINGE PARAFLUSHING IN PATIENTS WITH CENTRAL VENOUS CATHETER IN THE PERSPECTIVE OF HEALTH CAREERS

    Oct 1, 2019, 00:00

  • PCN12 COST-EFFECTIVENESS OF PEMBROLIZUMAB COMPARED TO CHEMOTHERAPY AS A TREATMENT FOR PATIENTS WITH PREVIOUSLY TREATED ADVANCED MELANOMA IN CHINA

    Oct 1, 2019, 00:00

  • PIH1 COSTOS DIRECTOS FARMACÉUTICOS EN PACIENTES ANCIANOS CON POLIFARMACIA EXTREMA MAYOR DE 20 MEDICAMENTOS EN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN37 FDA NEW DRUGS APPROVAL FOR BREAST, COLORECTAL, PROSTATE AND LUNG CANCER AND HORIZON SCANNING OPPORTUNITY

    Oct 1, 2019, 00:00

  • PCN63 COSTOS ASOCIADOS AL MANEJO DE PACIENTES CON CARCINOMA HEPATOCELULAR EN EL REGIMEN CONTRIBUTIVO

    Oct 1, 2019, 00:00

  • PUK5 POTENTIALLY INAPPROPRIATE PRESCRIPTIONS OF ANTICHOLINERGIC DRUGS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

    Oct 1, 2019, 00:00

  • PDB16 AVALIAÇÃO DA EFICÁCIA E SEGURANÇA DO USO DO METIMAZOL EM COMPARAÇÁO A PROPILTIOURACILA PARA HIPERTIREOIDISMO

    Oct 1, 2019, 00:00

  • CM4 TIME TO TREATMENT EFFECT, EVENT-FREE SURVIVAL, AND MOTOR MILESTONE ACHIEVEMENT IN TYPE I SPINAL MUSCULAR ATROPHY PATIENTS TREATED WITH ONASEMNOGENE ABEPARVOVEC (AVXS-101) OR NUSINERSEN CONTRASTED TO NATURAL HISTORY

    Oct 1, 2019, 00:00

  • PIH19 CONTRASTE DE MODELOS DE PROBABILIDAD DICOTOMICOS PARA LA ESTIMACION DE PARTOS Y CESAREAS EN UNA ENTIDAD PROMOTORA DE SALUD COLOMBIANA

    Oct 1, 2019, 00:00

  • PND19 RETROSPECTIVE ANALYSIS OF MULTIPLE SCLEROSIS TREATMENT PROFILE AND PATTERNS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

    Oct 1, 2019, 00:00

  • CR1 LOS COSTOS INDIRECTOS DE LA MORTALIDAD MATERNA EN BRASIL: UN ESTUDIO DE COSTOS DE ENFERMEDADES

    Oct 1, 2019, 00:00

  • PNS52 EQ-5D-5L SOCIAL VALUES IN PERU: A NOVEL "LITE” APPROACH

    Oct 1, 2019, 00:00

  • MT3 ICD THERAPY FOR SUDDEN CARDIAC ARREST PREVENTION IS POTENTIALLY COST-EFFECTIVE IN THE 1.5 PRIMARY PREVENTION POPULATION IN COLOMBIA: AN ECONOMIC EVALUATION OF THE IMPROVED SCA STUDY

    Oct 1, 2019, 00:00

  • PNS30 CHANGES IN THE OWNERSHIP STRUCTURE OF HUNGARIAN HEALTH CARE PROVIDERS

    Oct 1, 2019, 00:00

  • CM1 EFECTIVIDAD Y SEGURIDAD DE LA RESECCIÃN MUCOSA ENDOSCÃPICA FRENTE A LA DISECCIÃN SUBMUCOSA EN PACIENTES CON CÃNCER GÃSTRICO TEMPRANO: REVISIÃN SISTEMÃTICA CON METANÃLISIS

    Oct 1, 2019, 00:00

  • PDB13 ESTIMATION OF PATIENTS WITH INDICATION OF METABOLIC SURGERY IN THE PUBLIC AND PRIVATE SECTORS IN BRAZIL.

    Oct 1, 2019, 00:00

  • PMD1 PATIENT OUTCOMES IN CENTRIFUGE AND MEMBRANE THERAPEUTIC PLASMA EXCHANGE (TPE): LITERATURE REVIEW WITH A FOCUS ON THE CHILEAN COLOMBIAN MARKETS

    Oct 1, 2019, 00:00

  • PMS19 MANAGEMENT AND COSTS OF THERAPY FOR OSTEOARTHRITIS

    Oct 1, 2019, 00:00

  • PDB15 SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITOR IN TYPE 2 DIABETES: PRESCRIPTION PATTERNS AND TREATMENT OUTCOMES IN ARGENTINA

    Oct 1, 2019, 00:00

  • PMU6 ANALISIS DE COSTOS EN CUIDADO INTENSIVO Y CUIDADOS INTERMEDIOS DE UNA ASEGURADORA EN SALUD EN COLOMBIA

    Oct 1, 2019, 00:00

  • PDB7 COST COMPARISON OF BOVINE PERICARDIUM (BP) VS. BIOCOMPATIBLE GLYCOLIDE COPOLYMER BUTTRESS IN GASTRIC STAPLE LINE REINFORCEMENT (SLR)

    Oct 1, 2019, 00:00

  • PMU1 POTENTIAL PRODUCTIVITY YEARS OF LIFE LOST RELATED TO DEATHS CAUSED BY RESIDENTIAL RADON AND BONE LEAD IN COLOMBIA, 2016

    Oct 1, 2019, 00:00

  • HT4 EXPERIENCIAS INTERNACIONALES ACERCA DE LOS CRITERIOS DE DECISIÓN USADOS EN LA PRIORIZACIÓN DE LAS TECNOLOGÍAS DE SALUD

    Oct 1, 2019, 00:00

  • PRS3 IDIOPATHIC PULMONARY FIBROSIS EXACERBATIONS : DIRECT COSTS OF MEDICAL RESOURCES

    Oct 1, 2019, 00:00

  • PGI3 IMPACT OF DOSE ESCALATION ON TREATMENT COST OF IMMUNOBIOLOGICAL THERAPIES FOR CROHN'S DISEASE FROM THE BRAZILIAN PRIVATE PAYER PERSPECTIVE

    Oct 1, 2019, 00:00

  • PNS4 TRENDS FOR INTRODUCTION OF APPROVED DRUGS IN NETWORK META-ANALYSIS

    Oct 1, 2019, 00:00

  • PMH9 IMPACTO DE FACTORES SOCIOLOGICOS EN LA CALIDAD DE VIDA DE ADULTOS MAYORES INSTITUCIONALIZADOS CON DEPRESION: REVISION SISTEMATICA

    Oct 1, 2019, 00:00

  • PIH13 CLINICAL BURDEN AND COSTS ASSOCIATED WITH PNEUMOCOCCAL DISEASE HOSPITALIZATIONS IN OLDER ADULTS IN CURITIBA, BRAZIL

    Oct 1, 2019, 00:00

  • PRO12 LITERATURE REVIEW OF CHALLENGES AND OPPORTUNITIES IN HEALTH ECONOMIC EVALUATION METHODOLOGY IN RARE DISEASES

    Oct 1, 2019, 00:00

  • PNS9 BUDGET IMPACT OF NEW RECOMMENDATION FOR ATROPINIZATION IN BRAZILIAN GUIDELINES FOR ANTICOLINESTARASIS INTOXICATION

    Oct 1, 2019, 00:00

  • PCN58 CANCER PATIENTS PREFER REPORTING SYMPTOMS IN DAILY ELECTRONIC DIARIES AT HOME

    Oct 1, 2019, 00:00

  • PNS36 TRENDS IN UNITED STATES EMERGENCY DEAPARTMENT VISITS AND CHARGES, 2010-2016

    Oct 1, 2019, 00:00

  • PBI7 CASE STUDY: ECONOMICAL ANALYSIS OF WASTE IN BIOLOGICAL PRODUCTS IN AN INSTITUTION IN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN7 COSTOS DE LOS EVENTOS ADVERSOS ASOCIADOS CON EL TRATAMIENTO DEL MIELOMA MULTIPLE REFRACTARIO RECIDIVANTE (MMRR) EN ARGENTINA

    Oct 1, 2019, 00:00

  • PMH11 BURDEN OF MENTAL ILLNESS IN THE PRESENCE OF CHRONIC DISEASES IN THE BRAZILIAN PRIVATE HEALTH

    Oct 1, 2019, 00:00

  • PND1 COST-EFFECTIVENESS ANALYSIS OF CLADRIBINE IN HIGH DISEASE ACTIVITY RELAPSE REMITTING MULTIPLE SCLEROSIS IN ARGENTINA

    Oct 1, 2019, 00:00

  • PDG16 ACESSO A INFORMAÇÕES E SERVIÇOS PRESTADOS PELA SUPERINTENDÊNCIA DE ASSISTÊNCIA FARMACÊUTICA DO ESTADO DE MINAS GERAIS POR MEIO DO APLICATIVO MGAPP

    Oct 1, 2019, 00:00

  • PIH9 IMPACTO ECONOMICO DE ANEMIA Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PNS16 ANALYSIS OF THE DEMAND AND CONCESSIONS OF THE CONTINUED CASH BENEFIT FOR PERSONS WITH DISABILITIES UNDER 16 YEARS

    Oct 1, 2019, 00:00

  • PMD2 ANALISIS DE IMPACTO PRESUPUESTARIO Y SANITARIO POR LA INCORPORACION DE UN DISPOSITIVO PORTATIL PARA EL CONTROL DE LOS PACIENTES ANTICOAGULADOS EN LA POBLACION DEL INSTITUTO NACIONAL DE SERVICIOS SOCIALES PARA JUBILADOS Y PENSIONADOS (P ...

    Oct 1, 2019, 00:00

  • PIH15 CURRENT PANORAMA OF THE SURGICAL TREATMENT OF ENDOMETRIOSIS BY THE BRAZILIAN PUBLIC SYSTEM

    Oct 1, 2019, 00:00

  • PND18 THE RESTORE REGISTRY: A RESOURCE FOR MEASURING AND IMPROVING SPINAL MUSCULAR ATROPHY OUTCOMES

    Oct 1, 2019, 00:00

  • HT3 BASE DE COSTOS UNITARIOS EN SALUD EN ARGENTINA: UNA FUENTE DE INFORMACIÓN CONTINUAMENTE ACTUALIZADA PARA EVALUACIONES ECONOMICAS Y ANALISIS DE IMPACTO PRESUPUESTARIO EN UN SISTEMA DE SALUD FRAGMENTADO

    Oct 1, 2019, 00:00

  • PND3 COST-UTILITY ANALYSIS OF NATALIZUMAB AS FIRST LINE THERAPY FOR HIGHLY ACTIVE RELAPSING-REMITTING MULTIPLE SCLEROSIS FROM A BRAZILIAN PRIVATE PAYER PERSPECTIVE

    Oct 1, 2019, 00:00

  • PNS31 A VIA ADMINISTRATIVA COMO UMA ALTERNATIVA DE ACESSO AO MEDICAMENTO NO SISTEMA ÚNICO DE SAÚDE: SOLUÇÃO OU PROBLEMA?

    Oct 1, 2019, 00:00

  • PCN26 IMPACTO DE LAS RECAÍDAS EN LOS PACIENTES COLOMBIANOS CON LINFOMA FOLICULAR

    Oct 1, 2019, 00:00

  • PSY6 HUMANISTIC AND ECONOMIC BURDEN OF DISEASE FOR PSORIASIS IN ARGENTINA, BRAZIL, COLOMBIA AND MEXICO

    Oct 1, 2019, 00:00

  • PND7 COST-EFFECTIVENESS OF CLADRIBINE COMPARED TO NATALIZUMAB, OCRELIZUMAB AND ALEMTUZUMAB FOR THE TREATMENT OF PATIENTS WITH HIGHLY ACTIVE RELAPSING REMITTING MULTIPLE SCLEROSIS IN CHILE

    Oct 1, 2019, 00:00

  • PRS9 ESTIMATIVA DO CUSTO DA ASMA EM UM PLANO DE SAUDE NO BRASIL - ESTUDO DE MUNDO REAL

    Oct 1, 2019, 00:00

  • PNS37 REVIEW OF QUALITY AND PERFORMANCE INDICATORS RELATED TO INPATIENT CARE IN SELF-FUNDED HEALTH PLANS

    Oct 1, 2019, 00:00

  • PBI11 ESTUDIOS DE SINTESIS Y TOMA DE DECISIONES: A PROPOSITO DE LA CONTINUACION DEL TRATAMIENTO CON UN BIOSIMILAR EN PACIENTES QUE RECIBEN INFLIXIMAB EN EL SEGURO SOCIAL EN SALUD EN PERU

    Oct 1, 2019, 00:00

  • PCN51 SYSTEMATIC REVIEW AND META-ANALYSIS OF 18F-FDG PET-CT FOR INITIAL STAGING OF PATIENTS WITH ESOPHAGEAL CANCER

    Oct 1, 2019, 00:00

  • PCN46 ASSESSING THE QUALITY OF THE EVIDENCE OF NIVOLUMAB ACCORDING TO THE HTA REQUIREMENT IN ARGENTINA

    Oct 1, 2019, 00:00

  • PSY10 COST-EFFECTIVENESS ANALYSIS OF DRUG CHALLENGE TEST COMPARED TO SPECIFIC IGE DOSAGE FOR THE DIAGNOSIS OF PATIENTS WITH SUSPECT OF PENICILLIN ALLERGY

    Oct 1, 2019, 00:00

  • PNS50 ANALISIS DE IMPACTO DE LA IMPLEMENTACION DE UNA RED INTEGRADA MEDIANTE LA MEDIDA DE CALIDAD DE VIDA RELACIONADA CON LA SALUD EN POBLACION COLOMBIANA

    Oct 1, 2019, 00:00

  • PDB18 LA DIABETES Y SUS COMPLICACIONES EN LA ARGENTINA: EL CASO DEL PROGRAMA DE ATENCION INTEGRAL A LOS PACIENTES CON DIABETES MELLITUS EN LAS OBRAS SOCIALES NACIONALES

    Oct 1, 2019, 00:00

  • PMD10 ESTUDIO MULTICÉNTRICO DE COSTOS DEL RECAMBIO PLASMÁTICO TERAPÉUTICO (RPT) CON LOS SISTEMAS DE FILTRACIÓN TRANSMEMBRANA Y DE CENTRIFUGACIÓN EN COLOMBIA

    Oct 1, 2019, 00:00

  • RE3 RELAPSING-REMITTING MULTIPLE SCLEROSIS: COSTS BENEFITS OF EXPANDING COVERAGE FROM A PUBLIC PAYER PERSPECTIVE

    Oct 1, 2019, 00:00

  • PMD8 COST-EFFECTIVENESS OF THERMOABLATION VERSUS SURGERY FOR TREATMENT OF LIVER METASTASIS

    Oct 1, 2019, 00:00

  • PCN64 ANALISIS COMPARATIVO DE LOS COSTOS DEL PACIENTE CON CARCINOMA HEPATOCELULAR ENTRE REGIMENES CONTRIBUTIVO Y SUBSIDIADO

    Oct 1, 2019, 00:00

  • PBI9 MEDICATION USE AND REASONS FOR SWITCHING BIOLOGIC THERAPY IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: FINDINGS FROM A GLOBAL SURVEY

    Oct 1, 2019, 00:00

  • PND15 CHARACTERIZATION OF THE ARGENTINE POPULATION WITH AT LEAST 4 MONTHLY MIGRAINE DAYS: RESULTS FROM MIGRAINE VOICE SURVEY

    Oct 1, 2019, 00:00

  • CR3 COSTOS DIRECTOS Y CUMPLIMIENTO DE INDICADORES DE CONTROL METABOLICO EN PACIENTES CON DIABETES MELLITUS TIPO 2 EN UN HOSPITAL PUBLICO DE COLOMBIA

    Oct 1, 2019, 00:00

  • PCN21 ESTUDIO DE COSTO EFECTIVIDAD DE NIVOLUMAB PARA EL TRATAMIENTO DE SEGUNDA LINEA DEL CARCINOMA DE CELULAS RENALES METASTASICO DESDE LA PERSPECTIVA DEL SISTEMA DE SALUD PUBLICO CHILENO

    Oct 1, 2019, 00:00

  • MT1 ANÁLISIS COSTO-EFECTIVIDAD DE UN SISTEMA DE TROMBECTOMÍA REOLÍTICA PARA EL TRATAMIENTO DE LA ISQUEMIA AGUDA DE MIEMBROS INFERIORES EN ADULTOS MEXICANOS

    Oct 1, 2019, 00:00

  • PCN9 ANÁLISIS DE IMPACTO PRESUPUESTAL DE LA DETECCIÓN TEMPRANA DEL CÁNCER DE CUELLO UTERINO EN MUJERES DE 30 A 65 AÑOS MEDIANTE TAMIZACIÓN CON TEST DE VPH Y GENOTIPIFICACIÓN FRENTE CITOLOGÍA CONVENCIONAL, EN COLOMBIA

    Oct 1, 2019, 00:00

  • PMS2 SUCCESSFUL IMPLEMENTATION OF A COMPREHENSIVE CARE PROGRAM IN RHEUMATOID ARTHRITIS WITH SIGNIFICANT COST-SAVINGS FOR THE HEALTH SYSTEM

    Oct 1, 2019, 00:00

  • PMS20 DADOS DE MUNDO REAL DO USO DE IMUNOBIOLOGICOS DE PACIENTES COM ARTRITE REUMATOIDE

    Oct 1, 2019, 00:00

  • PMH3 ESKETAMINE SELF-PAY MODEL FOR TREATMENT RESISTANT DEPRESSION IN MEXICO

    Oct 1, 2019, 00:00

  • PNS25 COMPARING THE REMUNERATION OF HOSPITAL NURSES IN COUNTRIES WITH BISMARCK AND BEVERIDGE HEALTH CARE SYSTEMS

    Oct 1, 2019, 00:00

  • PIH10 NATIONWIDE, REAL-WORLD HEALTH INSURANCE TREATMENT COST OF INFERTILITY IN HUNGARY: A COST OF ILLNESS STUDY

    Oct 1, 2019, 00:00

  • PNS18 HOW IS SELF-PERCEIVED HEALTH STATUS (EQ-5D) ASSOCIATED WITH PSYCHOSOCIAL FACTORS IN 22 LATIN AMERICAN COUNTRIES?

    Oct 1, 2019, 00:00

  • PCN8 FINANCIAMIENTO DE MEDICAMENTOS ONCOLOGICOS MEDIANTE EL FONDO INTANGIBLE SOLIDARIO DE SALUD DEL PERU

    Oct 1, 2019, 00:00

  • PIN20 OVERVIEW OF MORTALITY DUE TO ANTIMICROBIAL RESISTANT INFECTIONS

    Oct 1, 2019, 00:00

  • PCV7 BUDGET IMPACT OF GLOBAL LONGITUDINAL STRAIN FOR THE EARLY DETECTION OF CARDIOTOXICITY INCORPORATION IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PNS48 USE OF REAL WORLD DATA FOR DEVELOPMENT OF AN ALGORITHM TO EVALUATE THE COMPLEXITY OF PEOPLE WITH CHRONIC DISEASES CONTROLLING FOR SOCIOECONOMIC AND ENVIRONMENTAL INEQUALITIES

    Oct 1, 2019, 00:00

  • PND16 PREFERENCES OF PATIENTS FOR FEATURES OF INJECTABLE, ORAL, AND INFUSED DISEASE-MODIFYING TREATMENTS FOR RELAPSE-REMITTING MULTIPLE SCLEROSIS

    Oct 1, 2019, 00:00

  • PNS15 DOES FOOD INSECURITY AFFECT PERFORMANCE AT SCHOOL? EVIDENCE FROM BRAZIL

    Oct 1, 2019, 00:00

  • PSU4 BUDGET IMPACT ANALYSIS OF TRICLOSAN-COATED SUTURES FOR SURGICAL SITE INFECTION PREVENTION IN COLOMBIA

    Oct 1, 2019, 00:00

  • CM3 REVIS SISTEMÃTICAS DOS MODELOS DE ORGANIZAÇÃO DE SISTEMAS PÚBLICOS DE SAÚDE PARA O CUIDADO DA OBESIDADE INFANTIL E SUA EFETIVIDADE NO MUNDO

    Oct 1, 2019, 00:00

  • PMD9 COST-EFFECTIVENESS ANALYSIS OF THREE-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY VERSUS TWO-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAM FOR THE EVALUATION OF PATIENTS WITH MITRAL REGURGITATION WITH INDICATION OF SURGICAL TREATMENT

    Oct 1, 2019, 00:00

  • PNS45 APPLYING A RAPID REVIEW METHODOLOGY TO INFORM THE UPDATE OF ARGENTINA'S HEALTH BENEFIT PACKAGE

    Oct 1, 2019, 00:00

  • EP1 SCHOOL ENVIRONMENT FACTORS ASSOCIATED WITH ADOLESCENTS BMI IN BRAZIL

    Oct 1, 2019, 00:00

  • PNS56 ESTIMACIÓN DEL COSTO DOMICILIARIO EN LAS ALTAS TEMPRANAS PARA PACIENTES NO CRÓNICOS EN UNA RED INTEGRAL DE SALUD

    Oct 1, 2019, 00:00

  • PCN35 BURDEN OF DISEASE FOR ADVANCED BREAST CANCER IN BRAZIL

    Oct 1, 2019, 00:00

  • PRO11 ANÁLISIS DE SERIE DE CASOS DE PACIENTES CON DIAGNÓSTICO DE HEMOFILIA A CON INHIBIDORES EN HOSPITALES DE ALTA COMPLEJIDAD EN ECUADOR

    Oct 1, 2019, 00:00

  • CL3 ESTUDIO DE EVALUACIÃN ECONÃMICA DEL APÃSITO TRANSPARENTE IMPREGNADO CON CLORHEXIDINA, PARA LA FIJACIÃN DE CATÃTERES CENTRALES BAJO EL CONTEXTO DE LOS HOSPITALES PÃBLICOS DE REPáBLICA DOMINICANA: CASO HOSPITAL DOCENTE PADRE BILLINI, AÃO ...

    Oct 1, 2019, 00:00

  • CR4 ESTIMATION OF THE ECONOMIC AND HEALTH EFFECTS OF CHRONIC KIDNEY DISEASE IN CHILEAN POPULATION OLDER THAN 60 YEARS OLD

    Oct 1, 2019, 00:00

  • PDG7 EVALUACION ECONOMICA DE DEXAMETASONA IMPLANTE PARA EL TRATAMIENTO DE PACIENTES CON EDEMA MACULAR DIABETICO CON FALLA A LA TERAPIA ANTI-VEGF (RANIBIZUMAB O AFLIBERCEPT)

    Oct 1, 2019, 00:00

  • PCN24 COST-EFFECTIVENESS OF NIVOLUMAB COMBINED WITH IPILIMUMAB IN FIRST-LINE TREATMENT OF ADVANCED MELANOMA FOR PATIENTS WITH BRAF+ MUTATION FROM A BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2019, 00:00

  • PIH6 APPROACH TO THE IMPACT OF COVERAGE IN LONG-TERM CONTRACEPTION IN THE ECONOMIC BURDEN OF UNPLANNED PREGNANCY FROM THE PERSPECTIVE OF ISAPRES IN CHILE

    Oct 1, 2019, 00:00

  • PAM3 COST MINIMIZATION BETWEEN READY TO USE OLIVE OIL-BASED PARENTERAL NUTRITION AND SUBROGATE COMPOUNDED PARENTERAL NUTRITION, ANALYSIS FROM A HIGH SPECIALITY REGIONAL MEXICAN HOSPITAL.

    Oct 1, 2019, 00:00

  • PIH3 BUDGET IMPACT ANALYSIS OF MEDICINES FOR CONTROLLED OVARIAN STIMULATION IN THE TREATMENT OF INFERTILITY IN PATIENTS WITH AN SUBOPTIMAL OVARIAN RESPONSE IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PRO9 PUBLIC PURCHASES OF ECULIZUMABE BY THE BRAZILIAN MINISTRY OF HEALTH: A PROFILE OF VOLUMES AND EXPENSES FROM 2007 TO 2018

    Oct 1, 2019, 00:00

  • PNS24 GASTOS COM MEDICAMENTOS E SEU IMPACTO NA RENDA DAS FAMÍLIAS BRASILEIRAS

    Oct 1, 2019, 00:00

  • PIN12 COST-EFFECTIVENESS OF INTERFERON-GAMMA RELEASE ASSAY COMPARED TO TUBERCULIN SKIN TEST FOR DETECTION OF LATENT TUBERCULOSIS IN RHEUMATOID ARTHRITIS PATIENTS USING IMMUNOBIOLOGICAL TREATMENTS

    Oct 1, 2019, 00:00

  • PDG15 SOLICITAÇÃO DE MEDICAMENTOS DO COMPONENTE ESPECIALIZADO NO ESTADO DE MINAS GERAIS: ESTRATÉGIA PARA REDUÇÃO DO TEMPO DE TRAMITAÇÃO E OTIMIZAÇÃO DESSE PROCESSO

    Oct 1, 2019, 00:00

  • PCN13 EVENTOS ADVERSOS ASOCIADOS A LOS TRATAMIENTOS DEL CARCINOMA UROTERIAL DE VEJIGA Y EL CARCINOMA DE CELULAS RENALES: ESTIMACION DE COSTOS DIRECTOS PARA ARGENTINA

    Oct 1, 2019, 00:00

  • PCN3 BRAND-BRAND ONCOLOGY COMBINATIONS: HURDLES AND IMPLICATIONS

    Oct 1, 2019, 00:00

  • PMS6 STANDARD COSTING OF DIRECT COSTS FOR PATIENTS WITH OSTEOARTHROSIS IN THE FIRST YEAR AFTER THE DISEASE WAS DIAGNOSED

    Oct 1, 2019, 00:00

  • PCN27 BUDGET IMPACT ANALYSIS OF MIDOSTAURIN IN PATIENTS WITH NEWLY DIAGNOSED FLT3 MUTATION-POSITIVE ACUTE MYELOID LEUKEMIA

    Oct 1, 2019, 00:00

  • PUK4 FACTORES ASOCIADOS DE LA PROGRESION DE LA ENFERMEDAD RENAL CRONICA EN UN PROGRAMA DE INTERVENCION DEL RIESGO CARDIOVASCULAR DEL CARIBE COLOMBIANO

    Oct 1, 2019, 00:00

  • PMS17 PATIENT PREFERENCES FOR BIOLOGIC AND BIOSIMILAR OSTEOPOROSIS TREATMENTS IN COLOMBIA: A DISCRETE-CHOICE EXPERIMENT

    Oct 1, 2019, 00:00

  • PBI8 O IMPACTO ECONOMICO DO PROCESSO DE VERTICALIZACAO NO USO DE IMUNOBIOLOGICOS INDICADOS PARA DOENCA DE CHRON EM UMA OPERADORA DE PLANOS DE SAUDE

    Oct 1, 2019, 00:00

  • PNS38 INVESTIGATING QUALITY AND PERFORMANCE INDICATORS RELATED TO OUTPATIENT CARE USING THE DELPHI METHOD

    Oct 1, 2019, 00:00

  • PDB2 SELF-MONITORING OF BLOOD GLUCOSE (SMBG) LEVELS IN SELECTED LATIN AMERICAN COUNTRIES — HOW DOES IT MEASURE UP TO MAJOR GLUCOSE MONITORING GUIDELINES?

    Oct 1, 2019, 00:00

  • CV1 CARDIOVASCULAR RISK IN DIABETES PATIENTS MONITORED BY A MOBILE PHONE APP HEALTH CARE PROGRAM IN BRAZIL

    Oct 1, 2019, 00:00

  • PCN55 CALIDAD DE VIDA RELACIONADA CON LA SALUD Y DESENLACES PERCIBIDOS POR PACIENTES CON CANCER DE MAMA EN COLOMBIA

    Oct 1, 2019, 00:00

  • PMU3 COSTOS DIRECTOS DE LA ATENCIÓN EN PACIENTES SUSCEPTIBLES DE CUIDADOS PALIATIVOS, EL CASO DE UNA ASEGURADORA EN SALUD EN COLOMBIA

    Oct 1, 2019, 00:00

  • PCV14 IMPACTO DE LA INTERVENCION FARMACEUTICA (IF) EN LA NO ADHERENCIA A TRATAMIENTOS POR OMISION DE RETIRO DE MEDICAMENTOS FINANCIADOS

    Oct 1, 2019, 00:00

  • PIN10 PUBLIC HEALTH AND ECONOMIC IMPACT OF A HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM FOR FEMALES AGED 9 YEARS IN EL SALVADOR

    Oct 1, 2019, 00:00

  • PNS32 COMPARATIVE ANALYSIS OF TENDER LEGISLATION IN BRAZIL AND MEXICO

    Oct 1, 2019, 00:00

  • PIH16 PATRONES DE USO DE ANTICONCEPTIVOS HORMONALES EN UNA POBLACIÓN DE COLOMBIA.

    Oct 1, 2019, 00:00

  • PMS4 MEDICATION PATTERNS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS - CHARACTERISTICS AND COSTS OF THERAPY

    Oct 1, 2019, 00:00

  • PIH8 MODEL TO APPROACH TO THE ECONOMIC BURDEN OF UNPLANNED PREGNANCY IN CHILE: THE IMPACT OF THE FAILURE OF COMPLIANCE OF THE CONTRACEPTIVE METHODS.

    Oct 1, 2019, 00:00

  • PNS40 IMPACTO DE LA IMPLEMENTACIÓN DE UNA RED DE ATENCIÓN INTEGRADA EN SERVICIOS DE SALUD EN LA POBLACIÓN DEL NOROCCIDENTE COLOMBIANO

    Oct 1, 2019, 00:00

  • PIT4 SILICONE TAPES FOR PATIENTS WITH FRAGILE SKIN: A SYSTEMATIC REVIEW

    Oct 1, 2019, 00:00

  • PIH11 ESTIMACION DE LA VARIACION DE COSTOS PRIVADOS E INSTITUCIONALES DE TRATAMIENTO DE LA DISMENORREA PRIMARIA EN MUJERES MEXICANAS.

    Oct 1, 2019, 00:00

  • PNS7 THE PRICE OF SUBSTITUTE TECHNOLOGIES

    Oct 1, 2019, 00:00

  • PND10 COMPARATIVE EFFECTIVENESS OF DELAYED-RELEASE DIMETHYL FURMURATE VERSUS OTHER DISEASE-MODIFYING THERAPIES IN PATIENTS WITH MULTIPLE SCLEROSIS: A DIRECT META-ANALYSIS OF REAL-WORLD EVIDENCE

    Oct 1, 2019, 00:00

  • PCN66 IDENTIFICATION OF PATIENTS UNDERGOING TREATMENT OF LUNG CANCER IN THE BRAZILIAN NATIONAL HEALTH SYSTEM (SUS)

    Oct 1, 2019, 00:00

  • PCN67 ANALYSIS OF TREATMENT PATTERNS FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN THE BRAZILIAN SUPPLEMENTARY HEALTHCARE SYSTEM IN DIFFERENT GEOGRAPHIC REGIONS OF BRAZIL

    Oct 1, 2019, 00:00

  • PIN27 USO DE LA REGRESIÓN BETA EN EL ANALISIS DE ASOCIACIÓN ENTRE LOS ÍNDICES EQ-5D-5L, EQ-EVA Y POTENCIALES COVARIABLES EN PACIENTES CON VIH/SIDA EN COLOMBIA

    Oct 1, 2019, 00:00

  • CE1 COSTO-EFECTIVIDAD DE UNA INTERVENCIÃN ECO-SISTÃMICA PARA EL CONTROL DEL DENGUE EN GIRARDOT-COLOMBIA DESDE LA PERSPECTIVA DE LA SOCIEDAD

    Oct 1, 2019, 00:00

  • EP3 CARACTERIZACIÓN EPIDEMIOLÓGICA DE PACIENTES CON ARTRITIS REUMATOIDE ATENDIDOS EN SISTEMA GENERAL DE SEGURIDAD SOCIAL EN SALUD DE COLOMBIA.

    Oct 1, 2019, 00:00

  • PIN13 BUDGET IMPACT ANALISIS ( BIA) OF THE IMPLEMENTATION OF HIGH-RISK HPV GENOTYPING IN PATIENTS OF THE SOCIAL SECURITY OF ECUADOR (IESS) FOR PREVENTION OF CERVICAL CANCER

    Oct 1, 2019, 00:00

  • PMU13 A MULTI-CRITERIA APPROACH TO THE STUDY OF CHRONIC NON-COMMUNICABLE DISEASES IN BRAZIL

    Oct 1, 2019, 00:00

  • PIH12 THE ECONOMIC IMPACT OF ENDOMETRIOSIS IN BRAZIL DUE TO PRODUCTIVITY LOSS

    Oct 1, 2019, 00:00

  • CR2 IMPACTO ECONOMICO DE CANCER DE MAMA Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PGI9 PRIOR DIAGNOSIS OF GASTROINTESTINAL DISORDER DOES NOT INCREASE KNOWLEDGE OF GASTROINTESTINAL TERMINOLOGY OR ACCURACY OF SYMPTOM RATING

    Oct 1, 2019, 00:00

  • PSU6 ESTUDIO DE COSTO EFECTIVIDAD ENTRE HEPARINA NO FRACCIONADA Y HEPARINAS DE BAJO PESO MOLECULAR EN PACIENTES SOMETIDOS A ARTROPLASTIA TOTAL DE CADERA ELECTIVA

    Oct 1, 2019, 00:00

  • RE2 Definiendo “Valor” en Latinoamérica: Lo bueno, lo malo y lo feo

    Oct 1, 2019, 00:00

  • PCN57 PATIENTS WITH CANCER VIEW PHYSICAL SYMPTOMS AND IMPACT OF SYMPTOMS AS IMPORTANT INFORMATION TO PROVIDE HEALTHCARE PROVIDERS ON A DAILY BASIS

    Oct 1, 2019, 00:00

  • CV2 MODELO PREDICTIVO DEL RIESGO DE MUERTE EN PACIENTES DIABETICOS APLICADO EN UNA COMPAÑIA DE ASEGURAMIENTO EN SALUD DE COLOMBIA

    Oct 1, 2019, 00:00

  • EP4 HOW IS SELF-PERCEIVED HEALTH STATUS (EQ-5D) ASSOCIATED WITH SOCIOECONOMIC CONDITIONS IN 22 LATIN AMERICAN COUNTRIES?

    Oct 1, 2019, 00:00

  • PIN7 ECONOMIC EVALUATION OF ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR ALAFENAMIDE (GENVOYA®) AS A COMPLETE TREATMENT REGIMEN FOR HIV-1 INFECTION IN ADULTS WHO ARE ANTIRETROVIRAL THERAPY-NAÏVE IN MEXICO

    Oct 1, 2019, 00:00

  • PIN21 PROFILING PURCHASE VOLUMES AND EXPENDITURES WITH DIRECT-ACTING ANTIRETROVIRALS FOR HEPATITIS C BY THE BRAZILIAN MINISTRY OF HEALTH, 2015-2018

    Oct 1, 2019, 00:00

  • PND17 THE BURDEN OF MIGRAINE IN LATIN AMERICA

    Oct 1, 2019, 00:00

  • PDG9 EVALUACIÓN PARA LA SELECCIÓN DE PRECIO MÁXIMO DE VENTA DE MEDICAMENTOS

    Oct 1, 2019, 00:00

  • PMU4 ESTIMATING THE ECONOMIC BURDEN OF DISEASE FROM WATER, SANITATION AND HYGIENE IN COLOMBIA

    Oct 1, 2019, 00:00

  • PND4 ANALISIS DE MINIMIZACION DE COSTOS DE TOPIRAMATO DE LIBERACION PROLONGADA PARA LA PREVENCION DE MIGRAÑA EN ADULTOS Y ADOLESCENTES A PARTIR DE LOS 12 AÑOS

    Oct 1, 2019, 00:00

  • CV3 COST-EFFECTIVENESS OF A COMPREHENSIVE INTERVENTION FOR HYPERTENSION CONTROL IN LOW-INCOME SETTINGS IN ARGENTINA: A MARKOV MODEL

    Oct 1, 2019, 00:00

  • PCN29 TENDENCIAS EN LA MORTALIDAD DEL CANCER DE MAMA EN COLOMBIA EN MUJERES MAYORES DE 60 AÑOS

    Oct 1, 2019, 00:00

  • PBI5 COST OF ADVERSE EVENTS ASSOCIATED WITH TREATMENT WITH BIOLOGICAL DRUGS IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS IN ARGENTINA

    Oct 1, 2019, 00:00

  • PMS8 CONVENTIONAL VERSUS BIOLOGICAL TREATMENT FOR ANKYLOSING SPONDYLITIS. RESULTS FROM A REAL-LIFE SETTING

    Oct 1, 2019, 00:00

  • PNS41 VALUE BASED HEALTH CARE (CUIDADO BASADO EM VALOR) EN AMERICA LATINA: RESULTADOS PRELIMINARES DE UNA INVESTIGACION CON 40 HOSPITALES DE CINCO PAISES LATINOAMERICANOS

    Oct 1, 2019, 00:00

  • PIT7 THE PROFILE OF FIREARMS INJURIES IN BRAZIL BETWEEN 2009 AND 2016

    Oct 1, 2019, 00:00

  • PCN53 EXAMINATION OF PATIENT DELAY AMONG PATIENTS DIAGNOSED WITH PROSTATE CANCER

    Oct 1, 2019, 00:00

  • PMH10 TREATMENT-RESISTANT DEPRESSION IN LATIN AMERICA: PRELIMINARY RESULTS FROM THE TRAL STUDY

    Oct 1, 2019, 00:00

  • PCN60 EVALUATION OF EMOTIONAL, SOCIAL AND ACCESS NEEDS OF PATIENTS DIAGNOSED WITH CHRONIC MYELOID LEUKEMIA IN COLOMBIA.

    Oct 1, 2019, 00:00

  • PDB1 CALIDAD DE VIDA ASOCIADA CON OBESIDAD EN PACIENTES MEXICANOS

    Oct 1, 2019, 00:00

  • RE4 PROPOSED SOLUTIONS TO ACHIEVING HEALTHCARE SUSTAINABILITY IN LATIN AMERICA

    Oct 1, 2019, 00:00

  • PIN4 A BUDGET IMPACTO ANALYSIS OF TENOFOVIR ALAFENAMIDE/EMTRICITABINE (DESCOVY®) FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION IN PATIENTS AGED 12 YEARS AND OLDER, IN MEXICO

    Oct 1, 2019, 00:00

  • PUK3 COST CONSEQUENCE ANALYSIS OF A REMOTE PATIENT MONITORING PROGRAM TO IMPROVE CLINICAL PRACTICE OF AUTOMATED PERITONEAL DYALISIS IN BRAZIL

    Oct 1, 2019, 00:00

  • PNS23 EPIDEMIOLOGY OF MYELOPROLIFERATIVE DISORDERS: REAL WORLD DATA STUDY IN BRAZIL

    Oct 1, 2019, 00:00

  • PDB12 BUDGET IMPACT ANALYSIS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN TYPE 1 DIABETES MELLITUS COMPARED WITH MULTIPLE DAILY INJECTIONS IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PDG1 POLIMIXINA B: EXISTEM FATORES DE RISCO ASSOCIADOS À NEFROTOXICIDADE EM PACIENTES QUE UTILIZARAM ESTE MEDICAMENTO?

    Oct 1, 2019, 00:00

  • PAM1 RESULTADOS DE LA IMPLEMENTACION DEL MODELO DE SOPORTE NUTRICIONAL EN LOS NIVELES HOSPITALARIO Y DOMICILIARIO

    Oct 1, 2019, 00:00

  • PRS4 HEALTH TECHNOLOGY ASSESSMENT OF DUPILUMAB IN SEVERE BRONCHIAL ASTHMA IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PSY9 PATRONES DE TRATAMIENTO FARMACOLOGICO EN PACIENTES ADULTOS CON DERMATITIS ATOPICA

    Oct 1, 2019, 00:00

  • PIN23 EVALUACIÓN DE LAS PROPIEDADES PSICOMÉTRICAS DEL EQ-5D-5L EN PACIENTES CON VIH/SIDA EN COLOMBIA

    Oct 1, 2019, 00:00

  • PBI6 EVALUATION OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN COLOMBIA: A COST PER RESPONDER ANALYSIS (CPR)

    Oct 1, 2019, 00:00

  • PNS35 THE EFFECT OF FINANCIAL INCENTIVE ON RETAINING DENTISTS IN RURAL AREAS IN THAILAND

    Oct 1, 2019, 00:00

  • HI3 EVIDENCIA DE LA VIDA REAL EN ARGENTINA: TRATAMIENTO DE PACIENTES CON HEPATITIS C EN EL SISTEMA DE TUTELAJE DE TECNOLOGIAS SANITARIAS EMERGENTES (STTSE)

    Oct 1, 2019, 00:00

  • PND9 BUDGET IMPACT ANALYSIS OF CLADRIBINE COMPARED TO THE CURRENT COVERAGE SCHEME IN CHILE TO TREAT PATIENTS WITH HIGHLY ACTIVE RELAPSING REMITTING MULTIPLE SCLEROSIS

    Oct 1, 2019, 00:00

  • PIN2 SISTEMA ELETRONICO INTEGRADO NO GERENCIAMENTO DO PROGRAMA STEWARDSHIP NUMA OPERADORA DE PLANOS DE SAUDE

    Oct 1, 2019, 00:00

  • PCN62 PRELIMIANARY ANALYSIS OF TIROSINE KINASE INHIBITOR THERAPY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA A FIVE YEARS FOLLOW-UP FROM A REAL WORLD COHORT

    Oct 1, 2019, 00:00

  • PMS16 COMPARING QUALITY OF LIFE, SYMPTOMS, AND TREATMENT PATTERNS OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS: FINDINGS FROM A GLOBAL SURVEY

    Oct 1, 2019, 00:00

  • PCN30 REAL-WORLD DATA FOR COSTS RELATED TO CANCER MANAGEMENT IN BRAZIL: AN OVERVIEW OF THE LITERATURE

    Oct 1, 2019, 00:00

  • HT1 TRANSFERIBILIDAD DE LAS EVALUACIONES ECONOMICAS PARA LA TOMA DE DECISIONES: UNA REVISION DE REVISIONES SISTEMATICAS

    Oct 1, 2019, 00:00

  • PND5 COST-EFFECTIVENESS OF MECHANICAL THROMBECTOMY USING SOLITAIRE STENT RETRIEVER IN COMBINATION WITH INTRAVENOUS TISSUE PLASMINOGEN ACTIVATOR (IV-TPA) VERSUS IV-TPA ALONE FOR THE TREATMENT OF ACUTE ISCHAEMIC STROKE DUE TO LARGE VESSEL OCC ...

    Oct 1, 2019, 00:00

  • PMU15 A MOBILE PHONE APP HEALTH CARE PROGRAM IN BRAZIL: SELF-REPORTS TO ASSESS DISEASE PREVALENCE

    Oct 1, 2019, 00:00

  • HI4 ADHERENCE TO TREATMENT IS ASSOCIATED WITH GOOD CLINICAL RESULTS IN PATIENTS TREATED WITH BIOLOGICAL THERAPY IN A CENTER OF EXCELLENCE IN RHEUMATOID ARTHRITIS

    Oct 1, 2019, 00:00

  • PIN5 CUSTO COM ANTIMICROBIANOS NO TRATAMENTO DE INFECCAO MULTIRRESISTENTE AOS CARBAPENEMICOS: VISAO DE UMA OPERADORA DE SAUDE

    Oct 1, 2019, 00:00

  • PNS2 COLOMBIA'S HEALTHCARE REFORM: COST-CONTAINMENT MECHANISMS AND IMPLICATIONS FOR SUSTAINABILITY

    Oct 1, 2019, 00:00

  • PCN19 ANÃLISE DO CUSTO-EFETIVIDADE DA RADIOTERAPIA COM INTENSIDADE MODULADA NO TRATAMENTO DO CÃNCER DE PRÃSTATA LOCALIZADO

    Oct 1, 2019, 00:00

  • PDB10 COST-EFFECTIVENESS ANALYSIS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN TYPE 1 DIABETES MELLITUS COMPARED WITH MULTIPLE DAILY INJECTIONS IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PMD5 ANALISIS DEL IMPACTO SANITARIO Y PRESUPUESTARIO POR LA INCORPORACION DEL TEST DE HPV CON GENOTIPIFICACION PARA EL TAMIZAJE PRIMARIO DE CANCER CERVICAL EN UNA POBLACION CERRADA DE UN HOSPITAL UNIVERSITARIO DE LA CIUDAD DE BUENOS AIRES

    Oct 1, 2019, 00:00

  • PSU7 COST-EFFECTIVENESS ANALYSIS OF APIXABAN FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER HIP OR KNEE REPLACEMENT SURGERY IN COLOMBIA

    Oct 1, 2019, 00:00

  • HI2 EVALUATION OF THE MEDICAL PROCEDURES ON AN ADMINISTRATIVE DATABASE TO IDENTIFY PATIENTS WITH SUSPECTED PRE-ECLAMPSIA IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PIH24 NUEVAMENTE: CALIDAD DE VIDA EN PERSONAS MAYORES DE UN SEGURO PRIVADO DE SALUD EN COLOMBIA

    Oct 1, 2019, 00:00

  • TP2 COSTS AND PRESCRIPTION PATTERN OF PATIENTS WITH PSORIATIC ARTHRITIS AND ITS ASSOCIATED COSTS

    Oct 1, 2019, 00:00

  • PMH1 COST-OF-ILLNESS STUDIES FOR DEPRESSION AND BIPOLAR DISORDER IN LATIN AMERICA: A SYSTEMATIC REVIEW

    Oct 1, 2019, 00:00

  • PCV10 EPIDEMIOLOGICAL STUDY DESIGN TO UNDERSTAND CARDIOVASCULAR RISK FACTORS AND TREATMENT IN GENERAL PRACTICE PATIENTS IN LATIN AMERICA

    Oct 1, 2019, 00:00

  • MT4 ANALISIS DE IMPACTO PRESUPUESTARIO SOBRE LA INCORPORACION DEL COCIENTE SFLT-1/PLGF PARA PREDECIR EL RIESGO DE PREECLAMPSIA EN LA COBERTURA DE LAS OBRAS SOCIALES NACIONALES DE ARGENTINA

    Oct 1, 2019, 00:00

  • PIN1 COST-EFFECTIVENESS ANALYSIS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE FOR HIGH RISK PATIENTS IN THE PERSPECTIVE OF BRAZILIAN NIP

    Oct 1, 2019, 00:00

  • PNS14 EVIDENCE ON THE POSTPONEMENT OF MATERNITY IN BRAZIL

    Oct 1, 2019, 00:00

  • PSU8 IS HIP ARTHROSCOPY COST EFFECTIVE IN TREATING FEMOROACETABULAR IMPINGEMENT? A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS

    Oct 1, 2019, 00:00

  • PDB9 ESTUDIO DE COSTOS DE LA HIPOGLICEMIA EN PACIENTES CON DIABETES MELLITUS TIPO 2 DESDE LA PERSPECTIVA DE SALUD PUBLICA DE CHILE

    Oct 1, 2019, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9 (current)
  • 10
  • »